Although there is little research investigating the relative benefits and risks of salt substitute use in such populations, people who have advanced CKD or who take medications that interfere with the renin-angiotensin-aldosterone axis, including potassium-sparing diuretics, may be suboptimal candidates for low-sodium salts that are enriched with potassium. This evidence concerns the gene REN and chronic kidney disease.